Atrial natriuretic peptide may inhibit motion sickness through reducing aldosterone-induced increase in endolymph volume of the inner ear
Qian-Cheng Lu, Wei Ji, Xia Li, Jian-Gang Ge, Li-Hua Xu, Zheng-Lin Jiang · 2026
Read Atrial natriuretic peptide may inhibit motion sickness through reducing aldosterone-induced increase in endolymph volume of the inner ear by Qian-Cheng Lu, Wei Ji, Xia Li, Jian-Gang Ge, Li-Hua Xu, Zheng-Lin Jiang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0359426.txt.
Description
Lu and five co-authors published a 2026 PLOS ONE study proposing a new angle on motion sickness. They suggest a heart hormone, atrial natriuretic peptide, may ease the sickness. The proposed route runs through aldosterone, another hormone, which can raise fluid volume in the inner ear. Motion sickness blights travel and training for many people, so a hormone-based route could open new treatments.
Catalog record
| CREATOR | Qian-Cheng Lu, Wei Ji, Xia Li, Jian-Gang Ge, Li-Hua Xu, Zheng-Lin Jiang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 46243 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |